查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1649466

薄膜製藥製造市場：預測（2025-2030）

Thin Film Drug Manufacturing Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

薄膜藥品製造市場預計在 2025 年價值 73.91 億美元，預計到 2030 年將達到 101.02 億美元，預測期內的複合年成長率為 6.45%。

薄膜藥物製造是製藥業的新興領域，專注於開發創新的藥物輸送系統。薄膜是含有活性藥物成分（API）的軟性層，可用於各種給藥途徑，包括口服、舌下、頰部和經皮。這些薄膜可快速溶解和崩壞，為傳統錠劑和膠囊提供快速且方便的替代品。該技術因其易於使用而越來越受到支持，尤其是對於難以吞嚥傳統劑型的兒科和老年患者。

薄膜製藥製造市場促進因素：

  • 非侵入性藥物輸送開發的創新：配方技術的進步和對非侵入性藥物輸送方法的需求不斷增加正在推動市場成長。薄膜藥物傳輸系統正在應用於疼痛治療、神經系統疾病和呼吸系統疾病的治療。此外，慢性病的增加和個人化醫療的需求進一步推動了這些系統的採用。

市場的主要企業正在大力投資研發，以加強其薄膜配方並擴大其產品組合。薄膜藥物輸送注重以患者為中心的藥物設計，確保更好的生物有效性和快速起效，被定位為一個有前途的創新領域。隨著這些產品的監管核准不斷增加，預計未來幾年市場將顯著成長。

薄膜製藥製造市場的地理展望：

  • 預計北美將主導市場：預計預測期內北美將佔據薄膜製藥製造市場的大部分佔有率。該地區的成長得益於薄膜技術的快速進步、電動幫浦的日益普及、新興的醫療保健基礎設施以及主要市場參與企業的持續產品創新。這些因素促進了消費群的強大和市場穩步發展。

此外，由於職業女性人口的成長和技術先進的吸乳器的需求增加，預計歐洲在此期間將以顯著的速度成長。企業進行宣傳宣傳活動宣傳穿戴式吸乳器的好處將大大提高市場滲透率。摘要，由於藥物輸送技術的創新、對非侵入性治療方案的需求不斷成長、慢性病患病率不斷上升、法規環境支持性以及關鍵區域發展（尤其是北美），薄膜製藥製造市場預計將見證顯著成長，從而加強這一不斷擴大的市場格局。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 收益成長和預測包括國家在內的細分市場和地區分析
  • 公司概況（策略、產品、財務、主要發展等）

薄膜藥品製造市場細分如下：

依產品類型：

  • 口腔薄膜
  • 經皮薄膜
  • 其他

依疾病類型：

  • 思覺失調症
  • 偏頭痛
  • 鴉片類成癮
  • 其他

按分銷管道

  • 醫院藥房
  • 零售藥局
  • 其他

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 其他
  • 中東和非洲
  • 沙烏地阿拉伯
  • 以色列
  • 其他
  • 亞太地區
  • 日本
  • 中國
  • 印度
  • 韓國
  • 印尼
  • 泰國
  • 其他

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析

5. 薄膜藥物製造市場（依產品類型）

  • 介紹
  • 口腔薄膜
  • 經皮薄膜
  • 其他

第6章 薄膜藥物製造市場（依疾病類型）

  • 介紹
  • 思覺失調症
  • 偏頭痛
  • 鴉片類成癮
  • 其他

7. 薄膜藥物製造市場（依分銷管道）

  • 介紹
  • 醫院藥房
  • 零售藥局
  • 其他

8. 薄膜製藥製造市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Pfizer
  • Novartis
  • ZIM LABORATORIES LIMITED
  • IntelGenx Corp.
  • AbbVie Inc.
  • Roche
  • Nova Thin Film Pharmaceuticals LLC
  • ARx, LLC.
  • LN LABORATORIES
  • Nissha Co., Ltd.
簡介目錄
Product Code: KSI061617242

The thin film drug manufacturing market is estimated at US$7.391 billion in 2025 and is anticipated to grow at a CAGR of 6.45% during the forecast period and reach US$10.102 billion in 2030.

Thin film drug manufacturing is an emerging sector within the pharmaceutical industry that focuses on developing innovative drug delivery systems. Thin films are flexible layers containing active pharmaceutical ingredients (APIs) designed for various administration routes, including oral, sublingual, buccal, or transdermal. These films dissolve or disintegrate quickly, offering a fast-acting and convenient alternative to traditional tablets and capsules. This technology has gained traction due to its ease of use, particularly for pediatric and geriatric patients who may struggle with swallowing conventional dosage forms.

Drivers of the Thin Film Drug Manufacturing Market:

  • Innovations in Non-Invasive Drug Development: Advances in drug formulation technologies and the rising demand for non-invasive drug delivery methods are driving market growth. Thin film drug delivery systems have therapeutic applications in pain management, neurological disorders, and respiratory conditions. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine further bolster the adoption of these systems.

Major players in the market are investing heavily in research and development to enhance film formulations and broaden their product offerings. The focus on patient-centric drug design, which promises better bioavailability and rapid onset of action, positions thin film drug delivery as a promising area for innovation. As regulatory approvals for these products increase, the market is expected to experience significant growth in the coming years.

Geographical Outlook of the Thin Film Drug Manufacturing Market:

  • North America Expected to Dominate the Market: North America is projected to hold a significant share of the thin film drug manufacturing market during the forecast period. The region's growth can be attributed to rapid advancements in thin film technologies, increased adoption of electric pumps, a well-developed healthcare infrastructure, and continuous product innovations by leading market players. These factors contribute to a robust consumer base and steady market development.

In addition, Europe is anticipated to grow at a notable rate during this period, driven by a rising population of working women and increasing demand for technologically advanced breast pumps. Companies' awareness campaigns promoting the benefits of wearable breast pumps significantly enhance market penetration. Favorable regulations and consumer preferences for innovative healthcare devices will also likely propel market growth in Europe.In summary, the thin film drug manufacturing market is set for substantial growth driven by innovations in drug delivery technologies, rising demand for non-invasive treatment options, increasing prevalence of chronic diseases, supportive regulatory environments, and significant geographical developments-especially within North America-that enhance this expanding market landscape.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Thin Film Drug Manufacturing Market has been segmented as following:

By Product Type:

  • Oral Thin Films
  • Transdermal Thin Films
  • Others

By Disease Type:

  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Geography:

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. THIN FILM DRUG MANUFACTURING MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Oral Thin Films
  • 5.3. Transdermal Thin Films
  • 5.4. Others

6. THIN FILM DRUG MANUFACTURING MARKET BY DISEASE TYPE

  • 6.1. Introduction
  • 6.2. Schizophrenia
  • 6.3. Migraine
  • 6.4. Opioid Dependence
  • 6.5. Others

7. THIN FILM DRUG MANUFACTURING MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Hospital Pharmacy
  • 7.3. Retail Pharmacy
  • 7.4. Others

8. THIN FILM DRUG MANUFACTURING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. UK
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. Israel
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Pfizer
  • 10.2. Novartis
  • 10.3. ZIM LABORATORIES LIMITED
  • 10.4. IntelGenx Corp.
  • 10.5. AbbVie Inc.
  • 10.6. Roche
  • 10.7. Nova Thin Film Pharmaceuticals LLC
  • 10.8. ARx, LLC.
  • 10.9. LN LABORATORIES
  • 10.10. Nissha Co., Ltd.